Hmdb loader
Record Information
Version5.0
StatusDetected and Quantified
Creation Date2006-08-12 19:07:11 UTC
Update Date2022-03-07 02:49:18 UTC
HMDB IDHMDB0003339
Secondary Accession Numbers
  • HMDB03339
Metabolite Identification
Common NameD-Glutamic acid
DescriptionThere are two forms of glutamic acid found in nature: L-glutamic acid and D-glutamic acid. D-glutamic acid, is not endogenously produced in higher mammals. It is found naturally primarily in the cell walls of certain bacteria. D-glutamate is also present in certain foods e.g., soybeans and also arises from the turnover of the intestinal tract microflora, whose cell walls contain significant D-glutamate. Unlike other D-amino acids, D-glutamate is not oxidized by the D-amino acid oxidases, and therefore this detoxification pathway is not available for handling D-glutamate. Likewise, D-glutamic acid, when ingested, largely escapes most deamination reactions (unlike the L-counterpart). Free D-glutamate is found in mammalian tissue at surprisingly high levels, with D-glutamate accounting for 9% of the total glutamate present in liver. D-glutamate is the most potent natural inhibitor of glutathione synthesis identified to date and this may account for its localization to the liver, since circulating D-glutamate may alter redox stabiity (PMID 11158923 ). Certain eels are known to use D-glutamic acid as a phermone for chemical communication. D-Glutamic acid has been found to be a metabolite of Lactobacillus (PMID: 22754309 ).
Structure
Data?1582752272
Synonyms
ValueSource
(R)-2-Aminopentanedioic acidChEBI
D-2-Aminoglutaric acidChEBI
D-Glutaminic acidChEBI
D-GlutaminsaeureChEBI
DGLChEBI
Glutamic acid D-formChEBI
(R)-2-AminopentanedioateGenerator
D-2-AminoglutarateGenerator
D-GlutaminateGenerator
Glutamate D-formGenerator
D-GlutamateGenerator
(2R)-2-AminopentanedioateHMDB
(2R)-2-Aminopentanedioic acidHMDB
D-2-AminopentanedioateHMDB
D-2-Aminopentanedioic acidHMDB
delta-2-AminoglutarateHMDB
delta-2-Aminoglutaric acidHMDB
delta-2-AminopentanedioateHMDB
delta-2-Aminopentanedioic acidHMDB
delta-GlutamateHMDB
delta-Glutamic acidHMDB
delta-GlutaminateHMDB
delta-Glutaminic acidHMDB
delta-GlutaminsaeureHMDB
GlutamateHMDB
Lopac-g-2128HMDB
Lopac-gamma-2128HMDB
R-(-)-GlutamateHMDB
R-(-)-Glutamic acidHMDB
Tocris-0217HMDB
Glutamic acid, (D)-isomerHMDB
L Glutamic acidHMDB
L-GlutamateHMDB
L-Glutamic acidHMDB
D GlutamateHMDB
Glutamate, potassiumHMDB
L-Glutamate, aluminumHMDB
Aluminum L glutamateHMDB
Glutamic acidHMDB
L GlutamateHMDB
Aluminum L-glutamateHMDB
Potassium glutamateHMDB
Chemical FormulaC5H9NO4
Average Molecular Weight147.1293
Monoisotopic Molecular Weight147.053157781
IUPAC Name(2R)-2-aminopentanedioic acid
Traditional NameD-glutamic acid
CAS Registry Number6893-26-1
SMILES
N[C@H](CCC(O)=O)C(O)=O
InChI Identifier
InChI=1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m1/s1
InChI KeyWHUUTDBJXJRKMK-GSVOUGTGSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as glutamic acid and derivatives. Glutamic acid and derivatives are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassCarboxylic acids and derivatives
Sub ClassAmino acids, peptides, and analogues
Direct ParentGlutamic acid and derivatives
Alternative Parents
Substituents
  • Glutamic acid or derivatives
  • Alpha-amino acid
  • D-alpha-amino acid
  • Amino fatty acid
  • Dicarboxylic acid or derivatives
  • Fatty acid
  • Fatty acyl
  • Amino acid
  • Carboxylic acid
  • Organic oxide
  • Primary amine
  • Organooxygen compound
  • Organonitrogen compound
  • Primary aliphatic amine
  • Organopnictogen compound
  • Carbonyl group
  • Organic oxygen compound
  • Amine
  • Organic nitrogen compound
  • Hydrocarbon derivative
  • Aliphatic acyclic compound
Molecular FrameworkAliphatic acyclic compounds
External Descriptors
Ontology
Not AvailableNot Available
Physical Properties
StateSolid
Experimental Molecular Properties
PropertyValueReference
Melting Point201 °CNot Available
Boiling PointNot AvailableNot Available
Water Solubility8.88 mg/mL at 25 °CNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility80.6 g/LALOGPS
logP-3.5ALOGPS
logP-3.2ChemAxon
logS-0.26ALOGPS
pKa (Strongest Acidic)1.88ChemAxon
pKa (Strongest Basic)9.54ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area100.62 ŲChemAxon
Rotatable Bond Count4ChemAxon
Refractivity31.29 m³·mol⁻¹ChemAxon
Polarizability13.19 ųChemAxon
Number of Rings0ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DarkChem[M+H]+132.66431661259
DarkChem[M-H]-125.32831661259
DeepCCS[M+H]+126.81530932474
DeepCCS[M-H]-122.9530932474
DeepCCS[M-2H]-160.54130932474
DeepCCS[M+Na]+135.92530932474
AllCCS[M+H]+133.832859911
AllCCS[M+H-H2O]+129.832859911
AllCCS[M+NH4]+137.632859911
AllCCS[M+Na]+138.632859911
AllCCS[M-H]-126.632859911
AllCCS[M+Na-2H]-128.832859911
AllCCS[M+HCOO]-131.232859911

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022.1.0 minutes32390414
Predicted by Siyang on May 30, 20229.2343 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20227.62 minutes32390414
AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid400.3 seconds40023050
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid484.2 seconds40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid318.7 seconds40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid40.7 seconds40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid195.1 seconds40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid67.9 seconds40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid287.9 seconds40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid220.1 seconds40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)836.1 seconds40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid584.5 seconds40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid39.3 seconds40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid677.2 seconds40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid198.7 seconds40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid277.0 seconds40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate725.9 seconds40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA480.3 seconds40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water478.6 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
D-Glutamic acidN[C@H](CCC(O)=O)C(O)=O2199.6Standard polar33892256
D-Glutamic acidN[C@H](CCC(O)=O)C(O)=O1237.6Standard non polar33892256
D-Glutamic acidN[C@H](CCC(O)=O)C(O)=O1815.6Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
D-Glutamic acid,1TMS,isomer #1C[Si](C)(C)OC(=O)CC[C@@H](N)C(=O)O1507.5Semi standard non polar33892256
D-Glutamic acid,1TMS,isomer #2C[Si](C)(C)OC(=O)[C@H](N)CCC(=O)O1472.0Semi standard non polar33892256
D-Glutamic acid,1TMS,isomer #3C[Si](C)(C)N[C@H](CCC(=O)O)C(=O)O1533.4Semi standard non polar33892256
D-Glutamic acid,2TMS,isomer #1C[Si](C)(C)OC(=O)CC[C@@H](N)C(=O)O[Si](C)(C)C1518.9Semi standard non polar33892256
D-Glutamic acid,2TMS,isomer #2C[Si](C)(C)N[C@H](CCC(=O)O[Si](C)(C)C)C(=O)O1617.6Semi standard non polar33892256
D-Glutamic acid,2TMS,isomer #3C[Si](C)(C)N[C@H](CCC(=O)O)C(=O)O[Si](C)(C)C1589.3Semi standard non polar33892256
D-Glutamic acid,2TMS,isomer #4C[Si](C)(C)N([C@H](CCC(=O)O)C(=O)O)[Si](C)(C)C1729.5Semi standard non polar33892256
D-Glutamic acid,3TMS,isomer #1C[Si](C)(C)N[C@H](CCC(=O)O[Si](C)(C)C)C(=O)O[Si](C)(C)C1625.8Semi standard non polar33892256
D-Glutamic acid,3TMS,isomer #1C[Si](C)(C)N[C@H](CCC(=O)O[Si](C)(C)C)C(=O)O[Si](C)(C)C1664.7Standard non polar33892256
D-Glutamic acid,3TMS,isomer #1C[Si](C)(C)N[C@H](CCC(=O)O[Si](C)(C)C)C(=O)O[Si](C)(C)C1807.9Standard polar33892256
D-Glutamic acid,3TMS,isomer #2C[Si](C)(C)OC(=O)CC[C@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C1779.5Semi standard non polar33892256
D-Glutamic acid,3TMS,isomer #2C[Si](C)(C)OC(=O)CC[C@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C1718.7Standard non polar33892256
D-Glutamic acid,3TMS,isomer #2C[Si](C)(C)OC(=O)CC[C@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C1969.6Standard polar33892256
D-Glutamic acid,3TMS,isomer #3C[Si](C)(C)OC(=O)[C@@H](CCC(=O)O)N([Si](C)(C)C)[Si](C)(C)C1765.0Semi standard non polar33892256
D-Glutamic acid,3TMS,isomer #3C[Si](C)(C)OC(=O)[C@@H](CCC(=O)O)N([Si](C)(C)C)[Si](C)(C)C1708.5Standard non polar33892256
D-Glutamic acid,3TMS,isomer #3C[Si](C)(C)OC(=O)[C@@H](CCC(=O)O)N([Si](C)(C)C)[Si](C)(C)C1949.2Standard polar33892256
D-Glutamic acid,4TMS,isomer #1C[Si](C)(C)OC(=O)CC[C@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C1804.2Semi standard non polar33892256
D-Glutamic acid,4TMS,isomer #1C[Si](C)(C)OC(=O)CC[C@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C1776.6Standard non polar33892256
D-Glutamic acid,4TMS,isomer #1C[Si](C)(C)OC(=O)CC[C@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C1746.4Standard polar33892256
D-Glutamic acid,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=O)CC[C@@H](N)C(=O)O1765.9Semi standard non polar33892256
D-Glutamic acid,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC(=O)[C@H](N)CCC(=O)O1743.3Semi standard non polar33892256
D-Glutamic acid,1TBDMS,isomer #3CC(C)(C)[Si](C)(C)N[C@H](CCC(=O)O)C(=O)O1797.0Semi standard non polar33892256
D-Glutamic acid,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=O)CC[C@@H](N)C(=O)O[Si](C)(C)C(C)(C)C1982.4Semi standard non polar33892256
D-Glutamic acid,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)N[C@H](CCC(=O)O[Si](C)(C)C(C)(C)C)C(=O)O2094.9Semi standard non polar33892256
D-Glutamic acid,2TBDMS,isomer #3CC(C)(C)[Si](C)(C)N[C@H](CCC(=O)O)C(=O)O[Si](C)(C)C(C)(C)C2043.8Semi standard non polar33892256
D-Glutamic acid,2TBDMS,isomer #4CC(C)(C)[Si](C)(C)N([C@H](CCC(=O)O)C(=O)O)[Si](C)(C)C(C)(C)C2168.8Semi standard non polar33892256
D-Glutamic acid,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)N[C@H](CCC(=O)O[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C2272.6Semi standard non polar33892256
D-Glutamic acid,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)N[C@H](CCC(=O)O[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C2259.4Standard non polar33892256
D-Glutamic acid,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)N[C@H](CCC(=O)O[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C2195.4Standard polar33892256
D-Glutamic acid,3TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC(=O)CC[C@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2433.4Semi standard non polar33892256
D-Glutamic acid,3TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC(=O)CC[C@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2321.6Standard non polar33892256
D-Glutamic acid,3TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC(=O)CC[C@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2263.8Standard polar33892256
D-Glutamic acid,3TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC(=O)[C@@H](CCC(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2427.8Semi standard non polar33892256
D-Glutamic acid,3TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC(=O)[C@@H](CCC(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2289.5Standard non polar33892256
D-Glutamic acid,3TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC(=O)[C@@H](CCC(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2256.1Standard polar33892256
D-Glutamic acid,4TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=O)CC[C@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2668.5Semi standard non polar33892256
D-Glutamic acid,4TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=O)CC[C@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2533.6Standard non polar33892256
D-Glutamic acid,4TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=O)CC[C@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2243.6Standard polar33892256
Spectra
Biological Properties
Cellular Locations
  • Cytoplasm (predicted from logP)
Biospecimen Locations
  • Blood
  • Breast Milk
  • Feces
  • Saliva
  • Urine
Tissue Locations
  • Epidermis
  • Fibroblasts
  • Intestine
  • Neuron
  • Placenta
  • Spleen
  • Testis
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected and Quantified0.0140-0.200 uMAdult (>18 years old)Not SpecifiedNormal details
Breast MilkDetected and Quantified1600 +/- 320 uMAdult (>18 years old)Female
Normal
details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Normal
details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Normal
details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Normal
details
FecesDetected but not QuantifiedNot QuantifiedNot SpecifiedNot Specified
Normal
details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Normal
details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Normal
details
FecesDetected but not QuantifiedNot QuantifiedInfant (0-1 year old)Both
Normal
details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)BothNormal details
FecesDetected but not QuantifiedNot QuantifiedChildren (6 - 18 years old)Not SpecifiedNormal details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Normal
details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Normal
details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Not Specified
Normal
details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Normal
details
FecesDetected and Quantified880 +/- 680 nmol/g wet fecesAdult (>18 years old)Both
Normal
details
FecesDetected and Quantified490 +/- 390 nmol/g wet fecesAdult (>18 years old)Both
Normal
details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Normal
details
FecesDetected and Quantified11382 nmol/g wet fecesAdult (>18 years old)Not Specified
Normal
details
FecesDetected and Quantified8923 nmol/g wet fecesAdult (>18 years old)Not Specified
Normal
details
FecesDetected and Quantified11117 nmol/g wet fecesAdult (>18 years old)Not Specified
Normal
details
SalivaDetected and Quantified43.4 +/- 55.1 uMAdult (>18 years old)Male
Normal
    • Sugimoto et al. (...
details
SalivaDetected and Quantified8.91 +/- 3.90 uMAdult (>18 years old)Both
Normal
    • Sugimoto et al. (...
details
SalivaDetected and Quantified123.84 +/- 110.2 uMAdult (>18 years old)BothNormal
    • Zerihun T. Dame, ...
details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal
details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal
details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal
details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal
details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal
details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal
details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal
details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal
details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal
details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal
details
SalivaDetected and Quantified67.51 +/- 75.14 uMAdult (>18 years old)FemaleNormal details
SalivaDetected and Quantified13.5 +/- 8.75 uMAdult (>18 years old)Female
Normal
    • Sugimoto et al. (...
details
SalivaDetected and Quantified14.5 +/- 19.8 uMAdult (>18 years old)Not Specified
Normal
    • Sugimoto et al. (...
details
SalivaDetected and Quantified14.5 +/- 6.75 uMAdult (>18 years old)Both
Normal
    • Sugimoto et al. (...
details
SalivaDetected and Quantified14.9 +/- 7.60 uMAdult (>18 years old)Not Specified
Normal
    • Sugimoto et al. (...
details
UrineDetected and Quantified7.9 +/- 3.9 umol/mmol creatinineAdult (>18 years old)BothNormal details
UrineDetected and Quantified<2.0 umol/mmol creatinineInfant (0-1 year old)Both
Normal
details
UrineDetected and Quantified<2.0 umol/mmol creatinineInfant (1 - 6 months old)Both
Normal
details
UrineDetected and Quantified<2.0 umol/mmol creatinineNewborn (0-30 days old)Both
Normal
details
UrineDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal
details
UrineDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal
details
UrineDetected and Quantified8.5 (3.3-18.4) umol/mmol creatinineAdult (>18 years old)Both
Normal
details
UrineDetected and Quantified2.6 umol/mmol creatinineAdult (>18 years old)BothNormal details
Abnormal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected and Quantified156.0 +/- 90.0 uMAdult (>18 years old)Both
Schizophrenia
details
BloodDetected and Quantified82.0 +/- 8.0 uMInfant (0-1 year old)Both
Premature
details
BloodDetected and Quantified0.429 uMAdult (>18 years old)Not SpecifiedGamma-glutamyltransferase deficiency details
BloodDetected and Quantified56.4 (12.69) uMAdult (>18 years old)FemalePregnancy details
BloodDetected and Quantified52.21 (14.83) uMAdult (>18 years old)FemalePregnancy with fetus having congenital heart defect details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Colorectal cancer
details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Colorectal cancer
details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Colorectal cancer
details
FecesDetected but not QuantifiedNot QuantifiedChildren (6 - 18 years old)Not SpecifiedUnclassified IBD details
FecesDetected but not QuantifiedNot QuantifiedChildren (6 - 18 years old)Not SpecifiedUlcerative colitis details
FecesDetected but not QuantifiedNot QuantifiedChildren (6 - 18 years old)Not SpecifiedCrohns disease details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Ulcerative colitis
details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Irritable bowel syndrome
details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Irritable bowel syndrome
details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Colorectal cancer
details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Ulcerative Colitis
details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Crohn’s Disease
details
SalivaDetected and Quantified47.82 +/- 18.36 uMAdult (>18 years old)BothLewy body disease details
SalivaDetected and Quantified43.79 +/- 10.57 uMAdult (>18 years old)MaleFrontotemporal lobe dementia details
SalivaDetected and Quantified38.26 +/- 29.05 uMAdult (>18 years old)MaleAlzheimer's disease details
UrineDetected and Quantified0.0064 umol/mmol creatinineAdult (>18 years old)BothADPKD details
Associated Disorders and Diseases
Disease References
Schizophrenia
  1. Heresco-Levy U, Bar G, Levin R, Ermilov M, Ebstein RP, Javitt DC: High glycine levels are associated with prepulse inhibition deficits in chronic schizophrenia patients. Schizophr Res. 2007 Mar;91(1-3):14-21. Epub 2007 Feb 2. [PubMed:17276036 ]
Pregnancy
  1. Bahado-Singh RO, Ertl R, Mandal R, Bjorndahl TC, Syngelaki A, Han B, Dong E, Liu PB, Alpay-Savasan Z, Wishart DS, Nicolaides KH: Metabolomic prediction of fetal congenital heart defect in the first trimester. Am J Obstet Gynecol. 2014 Sep;211(3):240.e1-240.e14. doi: 10.1016/j.ajog.2014.03.056. Epub 2014 Apr 1. [PubMed:24704061 ]
Gamma-glutamyltransferase deficiency
  1. Schulman JD, Goodman SI, Mace JW, Patrick AD, Tietze F, Butler EJ: Glutathionuria: inborn error of metabolism due to tissue deficiency of gamma-glutamyl transpeptidase. Biochem Biophys Res Commun. 1975 Jul 8;65(1):68-74. [PubMed:238530 ]
Crohn's disease
  1. Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, Wilson ID, Wang Y: Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res. 2007 Feb;6(2):546-51. [PubMed:17269711 ]
  2. Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158. [PubMed:27609529 ]
Ulcerative colitis
  1. Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, Wilson ID, Wang Y: Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res. 2007 Feb;6(2):546-51. [PubMed:17269711 ]
  2. Le Gall G, Noor SO, Ridgway K, Scovell L, Jamieson C, Johnson IT, Colquhoun IJ, Kemsley EK, Narbad A: Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J Proteome Res. 2011 Sep 2;10(9):4208-18. doi: 10.1021/pr2003598. Epub 2011 Aug 8. [PubMed:21761941 ]
  3. Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158. [PubMed:27609529 ]
Colorectal cancer
  1. Monleon D, Morales JM, Barrasa A, Lopez JA, Vazquez C, Celda B: Metabolite profiling of fecal water extracts from human colorectal cancer. NMR Biomed. 2009 Apr;22(3):342-8. doi: 10.1002/nbm.1345. [PubMed:19006102 ]
  2. Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
  3. Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
  4. Lin Y, Ma C, Liu C, Wang Z, Yang J, Liu X, Shen Z, Wu R: NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer. Oncotarget. 2016 May 17;7(20):29454-64. doi: 10.18632/oncotarget.8762. [PubMed:27107423 ]
Irritable bowel syndrome
  1. Ponnusamy K, Choi JN, Kim J, Lee SY, Lee CH: Microbial community and metabolomic comparison of irritable bowel syndrome faeces. J Med Microbiol. 2011 Jun;60(Pt 6):817-27. doi: 10.1099/jmm.0.028126-0. Epub 2011 Feb 17. [PubMed:21330412 ]
  2. Le Gall G, Noor SO, Ridgway K, Scovell L, Jamieson C, Johnson IT, Colquhoun IJ, Kemsley EK, Narbad A: Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J Proteome Res. 2011 Sep 2;10(9):4208-18. doi: 10.1021/pr2003598. Epub 2011 Aug 8. [PubMed:21761941 ]
Alzheimer's disease
  1. Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013 Sep 6. [PubMed:23857558 ]
Frontotemporal dementia
  1. Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013 Sep 6. [PubMed:23857558 ]
Lewy body disease
  1. Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013 Sep 6. [PubMed:23857558 ]
Autosomal dominant polycystic kidney disease
  1. Gronwald W, Klein MS, Zeltner R, Schulze BD, Reinhold SW, Deutschmann M, Immervoll AK, Boger CA, Banas B, Eckardt KU, Oefner PJ: Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine. Kidney Int. 2011 Jun;79(11):1244-53. doi: 10.1038/ki.2011.30. Epub 2011 Mar 9. [PubMed:21389975 ]
Associated OMIM IDs
DrugBank IDDB02517
Phenol Explorer Compound IDNot Available
FooDB IDFDB023148
KNApSAcK IDC00019577
Chemspider ID21814
KEGG Compound IDC00217
BioCyc IDD-GLT
BiGG IDNot Available
Wikipedia LinkGlutamic acid
METLIN ID6895
PubChem Compound23327
PDB IDNot Available
ChEBI ID15966
Food Biomarker OntologyNot Available
VMH IDGLU_D
MarkerDB IDMDB00000422
Good Scents IDNot Available
References
Synthesis ReferenceOzaki, Akio; Yagasaki, Makoto; Takada, Hideyoshi; Hashimoto, Yukio. Manufacture of D-glutamic acid with Lactobacillus. Jpn. Kokai Tokkyo Koho (1990), 4 pp.
Material Safety Data Sheet (MSDS)Download (PDF)
General References
  1. Emi M, Wilson DE, Iverius PH, Wu L, Hata A, Hegele R, Williams RR, Lalouel JM: Missense mutation (Gly----Glu188) of human lipoprotein lipase imparting functional deficiency. J Biol Chem. 1990 Apr 5;265(10):5910-6. [PubMed:1969408 ]
  2. Persson H, Pelto-Huikko M, Metsis M, Soder O, Brene S, Skog S, Hokfelt T, Ritzen EM: Expression of the neurotransmitter-synthesizing enzyme glutamic acid decarboxylase in male germ cells. Mol Cell Biol. 1990 Sep;10(9):4701-11. [PubMed:1697032 ]
  3. Ahlman B, Andersson K, Leijonmarck CE, Ljungqvist O, Hedenborg L, Wernerman J: Short-term starvation alters the free amino acid content of the human intestinal mucosa. Clin Sci (Lond). 1994 Jun;86(6):653-62. [PubMed:7914846 ]
  4. Wang M, Meng Z, Fu J: Synthesis and biodistribution of six novel 99mTc complexes of 2-hydroxybenzaldehyde-amino acid Schiff bases. Appl Radiat Isot. 2006 Feb;64(2):235-40. [PubMed:16309915 ]
  5. Majid SM, Liss AS, You M, Bose HR: The suppression of SH3BGRL is important for v-Rel-mediated transformation. Oncogene. 2006 Feb 2;25(5):756-68. [PubMed:16186799 ]
  6. Canal N, Nemni R: Autoimmunity and diabetic neuropathy. Clin Neurosci. 1997;4(6):371-3. [PubMed:9358982 ]
  7. Danke NA, Koelle DM, Yee C, Beheray S, Kwok WW: Autoreactive T cells in healthy individuals. J Immunol. 2004 May 15;172(10):5967-72. [PubMed:15128778 ]
  8. Guariso G, Brotto F, Basso D, Alaggio R, Betterle C: Organ-specific autoantibodies in children with Helicobacter pylori infection. Helicobacter. 2004 Dec;9(6):622-8. [PubMed:15610075 ]
  9. Nagai A, Suzuki Y, Baek SY, Lee KS, Lee MC, McLarnon JG, Kim SU: Generation and characterization of human hybrid neurons produced between embryonic CNS neurons and neuroblastoma cells. Neurobiol Dis. 2002 Oct;11(1):184-98. [PubMed:12460557 ]
  10. Mally MI, Cirulli V, Hayek A, Otonkoski T: ICA69 is expressed equally in the human endocrine and exocrine pancreas. Diabetologia. 1996 Apr;39(4):474-80. [PubMed:8777998 ]
  11. Maechler P, Gjinovci A, Wollheim CB: Implication of glutamate in the kinetics of insulin secretion in rat and mouse perfused pancreas. Diabetes. 2002 Feb;51 Suppl 1:S99-102. [PubMed:11815466 ]
  12. Nielsen C, Hansen D, Husby S, Jacobsen BB, Lillevang ST: No allelic variation in genes with high gliadin homology in patients with celiac disease and type 1 diabetes. Immunogenetics. 2004 Aug;56(5):375-8. Epub 2004 Aug 7. [PubMed:15309343 ]
  13. Luo J, Kaplitt MG, Fitzsimons HL, Zuzga DS, Liu Y, Oshinsky ML, During MJ: Subthalamic GAD gene therapy in a Parkinson's disease rat model. Science. 2002 Oct 11;298(5592):425-9. [PubMed:12376704 ]
  14. Meyer W, Poehling HM, Neurand K: Intraepidermal distribution of free amino acids in porcine skin. J Dermatol Sci. 1991 Sep;2(5):383-92. [PubMed:1742249 ]
  15. Cuervo JH, Rodriguez B, Houghten RA: The Magainins: sequence factors relevant to increased antimicrobial activity and decreased hemolytic activity. Pept Res. 1988 Nov-Dec;1(2):81-6. [PubMed:2980783 ]
  16. Roll U, Scheeser J, Standl E, Ziegler AG: Alterations of lymphocyte subsets in children of diabetic mothers. Diabetologia. 1994 Nov;37(11):1132-41. [PubMed:7867885 ]
  17. Bill JR, Mack DG, Falta MT, Maier LA, Sullivan AK, Joslin FG, Martin AK, Freed BM, Kotzin BL, Fontenot AP: Beryllium presentation to CD4+ T cells is dependent on a single amino acid residue of the MHC class II beta-chain. J Immunol. 2005 Nov 15;175(10):7029-37. [PubMed:16272364 ]
  18. Raj D, Langford M, Krueger S, Shelton M, Welbourne T: Regulatory responses to an oral D-glutamate load: formation of D-pyrrolidone carboxylic acid in humans. Am J Physiol Endocrinol Metab. 2001 Feb;280(2):E214-20. [PubMed:11158923 ]
  19. Zareian M, Ebrahimpour A, Bakar FA, Mohamed AK, Forghani B, Ab-Kadir MS, Saari N: A glutamic acid-producing lactic acid bacteria isolated from Malaysian fermented foods. Int J Mol Sci. 2012;13(5):5482-97. doi: 10.3390/ijms13055482. Epub 2012 May 7. [PubMed:22754309 ]

Enzymes

General function:
Involved in glutaminase activity
Specific function:
Plays an important role in the regulation of glutamine catabolism. Promotes mitochondrial respiration and increases ATP generation in cells by catalyzing the synthesis of glutamate and alpha-ketoglutarate. Increases cellular anti-oxidant function via NADH and glutathione production. May play a role in preventing tumor proliferation.
Gene Name:
GLS2
Uniprot ID:
Q9UI32
Molecular weight:
66322.225
Reactions
D-Glutamine + Water → D-Glutamic acid + Ammoniadetails
General function:
Involved in glutaminase activity
Specific function:
Catalyzes the first reaction in the primary pathway for the renal catabolism of glutamine. Plays a role in maintaining acid-base homeostasis. Regulates the levels of the neurotransmitter glutamate in the brain. Isoform 2 lacks catalytic activity.
Gene Name:
GLS
Uniprot ID:
O94925
Molecular weight:
65459.525
Reactions
D-Glutamine + Water → D-Glutamic acid + Ammoniadetails